The Failure of Vytorin and Statins to Improve Cardiovascular Health: Bad Cholesterol Or Bad Theory?
Journal of American Physicians and Surgeons 2008, Fall, 13, 3
-
- $5.99
-
- $5.99
Publisher Description
ABSTRACT The clinical failure of Vytorin in the ENHANCE trial supports the need to reevaluate the efficacy of widespread use of statin drugs for the treatment and prevention of coronary artery disease (CAD).
Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2001
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Biochemistry of Cardiovascular Dysfunction in Obesity
2020
Wild-type Food in Health Promotion and Disease Prevention
2008
Fasting Versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?(Perspectives)
2008
Relationship Among Plasma Secretory Phospholipase [a.Sub.2], Oxidized Low Density Lipoprotein & Paraoxonase Activities in Hypertensive Subjects Treated with Angiotensin Converting Enzyme Inhibitors (Report)
2009
Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview)
2008
Selective Serotonin: Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?(Report)
2009
Lessons from Sweden's Universal Health System: Tales from the Health-Care Crypt.
2008
Low-Fat Diet and Chronic Disease Prevention: The Women's Health Initiative and Its Reception.
2007
The Coase Theorem: The Greatest Economic Insight of the 20th Century.
2007
Conviction Without a Crime: A True Story (Viewpoint Essay)
2008